Sage Journals: Discover world-class research

Retricted access

Research article

First published 2013-8

Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data

Nicholas R. Latimer

Medical Decision Making

Retricted access

Review article

First published 2025-11

The Acceptance of Overall Survival Extrapolation Methods in Solid Tumor Treatments by Health Technology Assessment Agencies in England,France,and Australia between 2017 and 2022

Jean-Baptiste Trouiller, Arthur Quenéchdu, Mondher Toumi [...]

Medical Decision Making

Open access

Research article

First published 2023-4

Blended Survival Curves: A New Approach to Extrapolation for Time-to-Event Outcomes from Clinical Trials in Health Technology Assessment

Zhaojing Che, Nathan Green, Gianluca Baio

Medical Decision Making

Open access

Research article

First published 2022-10

Dynamic and Flexible Survival Models for Extrapolation of Relative Survival: A Case Study and Simulation Study

Benjamin Kearns, Matt D. Stevenson, Kostas Triantafyllopoulos [...]

Medical Decision Making

Retricted access

Research article

First published 2014-4

Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context

Nicholas R. Latimer, Keith R. Abrams, Paul C. Lambert [...]

Medical Decision Making

Open access

Research article

First published 2024-9

Risk for Revision ACLR After Primary All-Inside Quadrupled Semitendinosus Hamstring Tendon Autograft ACLR With Independent Suture Tape Augmentation: A Retrospective Cohort Study

Adam V. Daniel, Patrick A. Smith

Orthopaedic Journal of Sports Medicine

Open access

Review article

First published 2023-7

A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment

Ash Bullement, Matthew D. Stevenson, Gianluca Baio [...]

Medical Decision Making

Open access

Research article

First published 2025-7

Patient Preferences in Neoadjuvant Therapy for HER2+ Early-Stage Breast Cancer

Laurie Batchelder, Laure Guéroult-Accolas, Eirini Anastasaki [...]

MDM Policy & Practice

Search results